A Cross Company Perspective on the Assessment of Therapeutic Protein Biotransformation.

Walles, Markus; Berna, Michael; Jian, Wenying; Hauri, Simon; Hengel, Shawna; King, Lloyd; Tran, John C; Wei, Cong; Xu, Keyang; Zhu, Xiaochun

Walles, Markus; Berna, Michael; Jian, Wenying; Hauri, Simon; Hengel, Shawna; King, Lloyd; Tran, John C; Wei, Cong; Xu, Keyang; Zhu, Xiaochun.

Afiliação

Walles M; Pharmacokinetic Science, Novartis Institutes for Biomedical Research, Basel, Switzerland (M.W.); Biotechnology Discovery Research-ADME, Eli Lilly and Company, Indianapolis, Indiana (M.B.); Drug Metabolism and Pharmacokinetics, Janssen Research & Development, Spring House, Pennsylvania (W.J.); Ro
Berna M; Pharmacokinetic Science, Novartis Institutes for Biomedical Research, Basel, Switzerland (M.W.); Biotechnology Discovery Research-ADME, Eli Lilly and Company, Indianapolis, Indiana (M.B.); Drug Metabolism and Pharmacokinetics, Janssen Research & Development, Spring House, Pennsylvania (W.J.); Ro
Jian W; Pharmacokinetic Science, Novartis Institutes for Biomedical Research, Basel, Switzerland (M.W.); Biotechnology Discovery Research-ADME, Eli Lilly and Company, Indianapolis, Indiana (M.B.); Drug Metabolism and Pharmacokinetics, Janssen Research & Development, Spring House, Pennsylvania (W.J.); Ro
Hauri S; Pharmacokinetic Science, Novartis Institutes for Biomedical Research, Basel, Switzerland (M.W.); Biotechnology Discovery Research-ADME, Eli Lilly and Company, Indianapolis, Indiana (M.B.); Drug Metabolism and Pharmacokinetics, Janssen Research & Development, Spring House, Pennsylvania (W.J.); Ro
Hengel S; Pharmacokinetic Science, Novartis Institutes for Biomedical Research, Basel, Switzerland (M.W.); Biotechnology Discovery Research-ADME, Eli Lilly and Company, Indianapolis, Indiana (M.B.); Drug Metabolism and Pharmacokinetics, Janssen Research & Development, Spring House, Pennsylvania (W.J.); Ro
King L; Pharmacokinetic Science, Novartis Institutes for Biomedical Research, Basel, Switzerland (M.W.); Biotechnology Discovery Research-ADME, Eli Lilly and Company, Indianapolis, Indiana (M.B.); Drug Metabolism and Pharmacokinetics, Janssen Research & Development, Spring House, Pennsylvania (W.J.); Ro
Tran JC; Pharmacokinetic Science, Novartis Institutes for Biomedical Research, Basel, Switzerland (M.W.); Biotechnology Discovery Research-ADME, Eli Lilly and Company, Indianapolis, Indiana (M.B.); Drug Metabolism and Pharmacokinetics, Janssen Research & Development, Spring House, Pennsylvania (W.J.); Ro
Wei C; Pharmacokinetic Science, Novartis Institutes for Biomedical Research, Basel, Switzerland (M.W.); Biotechnology Discovery Research-ADME, Eli Lilly and Company, Indianapolis, Indiana (M.B.); Drug Metabolism and Pharmacokinetics, Janssen Research & Development, Spring House, Pennsylvania (W.J.); Ro
Xu K; Pharmacokinetic Science, Novartis Institutes for Biomedical Research, Basel, Switzerland (M.W.); Biotechnology Discovery Research-ADME, Eli Lilly and Company, Indianapolis, Indiana (M.B.); Drug Metabolism and Pharmacokinetics, Janssen Research & Development, Spring House, Pennsylvania (W.J.); Ro
Zhu X; Pharmacokinetic Science, Novartis Institutes for Biomedical Research, Basel, Switzerland (M.W.); Biotechnology Discovery Research-ADME, Eli Lilly and Company, Indianapolis, Indiana (M.B.); Drug Metabolism and Pharmacokinetics, Janssen Research & Development, Spring House, Pennsylvania (W.J.); Ro

Drug Metab Dispos ; 50(6): 846-857, 2022 06.

Article em En | MEDLINE | ID: mdl-35306476

Assuntos

Produtos Biológicos; Indústria Farmacêutica; Biotransformação; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Produtos Biológicos / Indústria Farmacêutica Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Drug Metab Dispos Assunto da revista: FARMACOLOGIA Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google